|Therapeutic Area||Formulary Choices||Cost for 28|
(unless otherwise stated)
|Rationale for decision / comments|
|11.6 Treatment of glaucoma|
As advised by secondary care
|Where a prostaglandin analogue is indicated for reducing IOP, Latanoprost is the recommended first line agent on grounds of cost (generic form available) and ocular tolerability.
Patients currently using other forms of prostaglandin analogues may be reviewed when seen routinely by secondary care.
|First line:||Latanoprost||50mcg/ml: £1.48 (2.5ml)||Xalatan is an expensive brand and comes with the following warning
Latanoprost (Xalatan®): increased reporting of eye irritation since reformulation (July 2015)
Following reformulation of Xalatan®, to allow for long-term storage at room temperature, there has been an increase in the number of reports of eye irritation from across the EU.
|Preservative-free single use|
|50mcg/ml: £8.49 (30x0.2ml)||For the reduction of elevated intra-ocular pressure in patients with open-angle glaucoma and ocular hypertension who have proven sensitivity to benzalkonium chloride|
|2.5mg/ml £8.45 (5ml)|
5mg/ml £9.65 (5ml)
|Ocular hypertension, chronic open-angle glaucoma|
|Dorzolomide 2% P/F eye drops |
|Dorzolomide 2% and timolol 5mg/ml P/F eye drops|